Korea Health Industry Development Institute Hosts Digital Healthcare Global Capacity Building Seminar

[Asia Economy Reporter Chunhee Lee] The Korea Health Industry Development Institute announced on the 24th that it will hold the '1st Digital Healthcare Global Capacity Building Seminar' at The-K Hotel in Seocho-gu, Seoul on the 1st of next month.

This event was organized to strengthen global capabilities to support domestic digital healthcare companies in pioneering overseas markets and to discover promising digital healthcare technologies and products. It is hosted by the Ministry of Health and Welfare and jointly organized by the Development Institute and the Korea Smart Healthcare Association.

To globalize digital healthcare, experts from industry, academia, research, and hospitals will participate targeting digital healthcare-related companies interested in overseas expansion. They will discuss global market trends in digital healthcare, share cases of overseas expansion support, and discuss support measures. The seminar is scheduled to be held three times by the end of the year with various themes.

This seminar will proceed in the order of ▲Prospects of Digital Therapeutics (DTx) and current status of overseas expansion support ▲DTx development cases and overseas expansion strategies ▲Panel discussion on DTx commercialization and overseas expansion support measures. There will also be Q&A sessions and networking time with experts on each topic, expected to be a lively platform for information sharing.

In the first session, Juyoung Kim, Co-chair of the Asia-Pacific Task Group of the DTx Association (DTA), will present 'Global Market Status and Prospects from the Perspective of DTA,' Seungsu Baek, Head of the ICT Convergence International Medical Team at the Development Institute, will present 'Current Status and Future Plans for Supporting Overseas Expansion of ICT-based Medical Systems,' and Hongjin Jeon, Professor of Psychiatry at Samsung Seoul Hospital, will present 'Current Status and Future Prospects of Global DTx.'

In the second session, Byeongho Nam, CEO of Herings, Yujin Lee, Director of Welt, and Jungsang Min, CEO of Emotive, will present their respective DTx development cases. Young Kim, CEO of Synex, will present DTx regulatory approval strategies, and Boram Shim, Associate Researcher at the Health Insurance Review and Assessment Service, will present 'Understanding DTx Policies and Insurance.'

In the subsequent panel discussion, Jinwook Shin, Professor at Yonsei University, Taehyung Kim, Head of the Pan-Government Lifecycle Medical Device R&D Project Group, and Haengshin Lee, Director of the International Medical Strategy Team at the Development Institute, will participate to discuss future overseas expansion strategies and derive implications.

This content was produced with the assistance of AI translation services.